ASCO GU 2008 - Disease Trajectory Of Untreated Localized Prostate Cancer In Elderly Men: A Population-Based Study
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology; Men's health; Seniors / Aging
Article Date: 24 Feb 2008 - 0:00 PDT
| Patient / Public: | ![]() |
5 (2 votes) |
| Healthcare Prof: | ![]() |
UroToday.com - Overtreatment of CaP affects QOL for patients. The prostate cancer specific mortality (PCSM) that is decreased by radical prostatectomy (RP) in the Bill-Axelsen study is mostly seen in men younger than 65 years, and most of these men did not have screen-detected CaP. The majority of patients diagnosed in the US are greater than age 65. This present study included 9,018 men from 1992-2002, with more than 5,000 men aged >75 years. 100% had T1-T2 disease and none had initial treatment. This group thus varied from other watchful waiting studies by Albertsen and Johansson.
This population based cohort used the SEER-Medicare data, and subjects had no other cancer, were aged >65 years and had T1-T2 CaP diagnosed in 1992-2002. They assessed CaP related disease morbidities. The median age was 77 years, with 11.7% African-American men and most with Gleason score 5-7 tumors. 64% were stage T1.
The 10-year chance of PCSM was less than 10%, unless it was high risk disease. The death from other causes was over 50%. The cancer morbidity rate was <8%. The overall risk of PCSM in all age groups was 12-15%. This study was population based which limits biased, but it lacked PSA values at diagnosis and only had composite Gleason scores.
Presented by G. Lu-Yao at the American Society of Clinical Oncology (ASCO) - 2008 Genitourinary Cancers Symposium - A Multidisciplinary Approach - February 14-16, 2008 San Francisco, California, USA
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS Professor & Chairman Department of Urology University of California, Davis, School of Medicine Sacramento, CA
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/98365.php>
APA
http://www.medicalnewstoday.com/releases/98365.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




